S0508

Sulfamonomethoxine

Name: Sulfamonomethoxine
Brand: SIGMA
Price: 909 ILS

Synonym(s):

4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide, 4-Methoxy-6-sulfanilamidopyrimidine, N¹-(6-Methoxy-4-pyrimidinyl)sulfanilamide, SMM

Slide 1 of 2

Select a Size

250 MG

₪909.00

Please contact Customer Service for Availability

Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):

C₁₁H₁₂N₄O₃S

CAS Number:

1220-83-3

Molecular Weight:

280.30

UNSPSC Code:

51283946

NACRES:

NA.85

PubChem Substance ID:

24899439

MDL number:

MFCD00063466

Beilstein/REAXYS Number:

621128

Key Documents

View All Documentation

InChI

1S/C11H12N4O3S/c1-18-11-6-10(13-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,14,15)

SMILES string

COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1

InChI key

WMPXPUYPYQKQCX-UHFFFAOYSA-N

form

powder

color

white to yellow-white

solubility

methanol: soluble 10 mg/mL

antibiotic activity spectrum

Gram-negative bacteria
Gram-positive bacteria
parasites

mode of action

DNA synthesis | interferes
enzyme | inhibits

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Related Categories

Antibiotics

Biochemicals

Cell Culture Supplements & Reagents

Chemistry & Biochemicals

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	S6256	32091	S5637
Sigma-Aldrich S0508 Sulfamonomethoxine	Sigma-Aldrich S6256 Sulfamethazine	Supelco 32091 Sulfamonomethoxine	Sigma-Aldrich S5637 Sulfamethazine sodium salt
antibiotic activity spectrum Gram-negative bacteria, parasites, Gram-positive bacteria	antibiotic activity spectrum Gram-negative bacteria, Gram-positive bacteria	antibiotic activity spectrum -	antibiotic activity spectrum Gram-negative bacteria, Gram-positive bacteria
mode of action DNA synthesis \| interferes, enzyme \| inhibits	mode of action DNA synthesis \| interferes, enzyme \| inhibits	mode of action -	mode of action DNA synthesis \| interferes, enzyme \| inhibits
Quality Level 200	Quality Level 200	Quality Level 100	Quality Level 200
form powder	form powder or crystals	form -	form powder
solubility methanol: soluble 10 mg/mL	solubility -	solubility -	solubility H₂O: soluble 50 mg/mL
color white to yellow-white	color white to off-white	color -	color white to off-white

Application

Sulfamonomethoxine is used to study degradation by Fe³O⁴ magnetic nanoparticles[1]. It is used in blood kinetic studies and is used to study capsule formation of Bordetella bronchiseptica[2][3].

Biochem/physiol Actions

Sulfamonomethoxine is a competitive inhibitor of dihydropteroate synthetase used to block the synthesis of folic acid.

General description

Chemical structure: sulfonamide

Other Notes

Keep container tightly closed in a dry and well-ventilated place.

pictograms

GHS07

signalword

Warning

hcodes

H315,H317,H319,H335

pcodes

P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Inhibitory effect of sulfamonomethoxine on capsule formation of Bordetella bronchiseptica.

A Kuwano

Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B, 38(9), 685-688 (1991-11-01)

Bordetella bronchiseptica phase I organism possesses a capsule and has the ability to agglutinate with K antiserum, although phase III organism lacks both. The present study examines the effect of sulfamonomethoxine (SMMX) on capsule formation of B. bronchiseptica. I also

Blood kinetics of sulfamonomethoxine and oxytetracycline following intrauterine spray injection in dairy cows.

C Girardi et al.

Pharmacological research, 22(2), 79-86 (1990-03-01)

Intrauterine administration was performed in six Friesan cows with a disposable spray preparation containing 3 g of sulfamonomethoxine and 3 g of oxytetracycline, in order to investigate their serum kinetics. Sulfamonomethoxine levels were determined by a reversed-phase HPLC method, whilst

Automated benchmarking of peptide-MHC class I binding predictions.

Thomas Trolle et al.

Bioinformatics (Oxford, England), 31(13), 2174-2181 (2015-02-27)

Numerous in silico methods predicting peptide binding to major histocompatibility complex (MHC) class I molecules have been developed over the last decades. However, the multitude of available prediction tools makes it non-trivial for the end-user to select which tool to

Degradation of sulfamonomethoxine with Fe3O4 magnetic nanoparticles as heterogeneous activator of persulfate.

Jingchun Yan et al.

Journal of hazardous materials, 186(2-3), 1398-1404 (2011-01-18)

Iron oxide magnetic nanoparticles (Fe(3)O(4) MNPs) can effectively activate persulfate anions (S(2)O(8)(2-)) to produce sulfate free radicals (SO(4)(-)), which are a powerful oxidant with promising applications to degrade organic contaminants. The kinetics of sulfamonomethoxine (SMM) degradation was studied in the

Systematic synthesis and MAG-binding activity of novel sulfated GM1b analogues as mimics of Chol-1 (alpha-series) gangliosides: highly active ligands for neural siglecs.

Hiromi Ito et al.

Carbohydrate research, 338(16), 1621-1639 (2003-07-23)

Systematic synthesis and myelin-associated glycoprotein (MAG)-binding activity of novel sulfated GM1b analogues structurally related to Chol-1 (alpha-series) gangliosides, high-affinity ligands for neural siglecs, are described. The suitably protected gangliotriose derivatives, 2-(trimethylsilyl)ethyl 2-acetamido-2-deoxy-6-O-levulinoyl-beta-D-galactopyranosyl-(1-->4)-2,3,6-tri-O-benzyl-beta-D-galactopyranosyl-(1-->4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside and 2-(trimethylsilyl)ethyl 2-acetamido-2-deoxy-6-O-levulinoyl-beta-D-galactopyranosyl-(1-->4)-2,6-di-O-benzyl-3-O-levulinoyl-beta-D-galactopyranosyl-(1-->4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside were each glycosylated with alpha-NeuAc-(2-->3)-galactose

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service